Berkman Charles S

Average Profitability
29.71%
Insider Buys Quantity
4
Insider Buys Sum
$41,343.00
Insider Sells Quantity
15
Insider Sells Sum
$11.78M

Insider Activity of Berkman Charles S

According to the SEC Form 4 filings, Berkman Charles S, being in a position of

  1. Chief Legal Officer at OmniAb, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6954 shares for $36,648,
    over all time since 2024-04-08, has bought 0 shares, and sold 6954 shares for $36,648.

The largest purchase of all time was on 2014-06-30 and amounted to 329 shares of Ligand Pharmaceuticals Incorporated for $14,408.

The largest sale of all time was on 2018-09-04 and amounted to 19417 shares of Ligand Pharmaceuticals Incorporated for $4.95M.

Biography of Berkman Charles S

No biography is available at this moment.

2024-04-08SaleOmniAb, Inc.
OABI
Chief Legal Officer
6,954
0.0059%
$5.27$36,648-16.76%
2018-09-17SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
2,813
0.0053%
$100.38$282,369-52.38%
2018-09-04SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
19,417
0.0906%
$254.99$4.95M-52.36%
2017-08-09SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
18,625
0.0884%
$126.96$2.36M+21.97%
2016-08-05SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
4,295
0.0205%
$123.16$528,972-13.34%
2015-07-10SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
14,067
0.0703%
$99.14$1.39M+2.58%
2015-03-16SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
6,000
0.0305%
$74.51$447,060+26.7%
2014-12-31PurchaseLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
126
0.0005%
$45.23$5,699+68.77%
2014-06-30PurchaseLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
329
0.0011%
$43.79$14,408-11.18%
2014-05-27SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
4,667
0.0224%
$66.89$312,176-17.55%
2014-02-12SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
2,122
0.003%
$21.70$46,048-25.46%
2013-12-31PurchaseLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
209
0.0007%
$33.91$7,088+10.18%
2013-08-30SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
9,499
0.0461%
$47.54$451,576+20.5%
2013-08-16SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
14,583
0.0709%
$42.63$621,732+34.58%
2013-06-28PurchaseLigand Pharmaceuticals Incorporated
LGND
VP, Gen. Counsel & Secretary
815
0.0019%
$17.36$14,148+51.07%
2013-05-10SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
4,000
0.0197%
$26.66$106,640+95.09%
2012-09-07SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
4,249
0.0215%
$18.77$79,754+21.97%
2012-03-08SaleLigand Pharmaceuticals Incorporated
LGND
SVP, Gen. Counsel & Secretary
3,606
0.0182%
$15.76$56,832+10.75%
2011-02-16SaleLigand Pharmaceuticals Incorporated
LGND
VP, Gen. Counsel & Secretary
10,000
0.0484%
$9.75$97,501+14.31%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.